Paolo Morabito

Paolo Morabito is an experienced professional in pharmacovigilance and medical management, currently serving as the Pharmacovigilance Safety Director and Deputy EU/UK QPPV at Kedrion Biopharma from March 2024 to June 2025. Previously, Paolo held various roles at MENARINI Group from March 2017 to April 2021, including responsibilities in signal detection and medical assessment. Prior experience includes working as an Area Specialist/Medical Writer at Merck & Co. and as a Medical Science Manager at Bristol-Myers Squibb, focusing on immunotherapy in oncology. Paolo began his career as a Medico di Continuità Assistenziale at ASP Reggio Calabria in 2015. Paolo holds a degree in Medicine and Surgery from the University of Messina and an MBA in Email Marketing Management from E-Business Academy.